Hambach, L <br/><br/>
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.  [electronic resource] 

 -  Bone marrow transplantation  Oct 2001 
 - 705-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Bone Marrow Transplantation<br/>Combined Modality Therapy<br/>Cyclosporine--therapeutic use<br/>Cystitis--drug therapy<br/>Cytarabine--administration & dosage<br/>Cytomegalovirus Infections--drug therapy<br/>DNA, Neoplasm--genetics<br/>Female<br/>Foscarnet--therapeutic use<br/>Ganciclovir--therapeutic use<br/>Graft vs Host Disease--drug therapy<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Histocompatibility<br/>Humans<br/>Hydroxyurea--administration & dosage<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon-alpha--administration & dosage<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Methotrexate--therapeutic use<br/>Mitoxantrone--administration & dosage<br/>Neoplasms, Second Primary--drug therapy<br/>Prednisolone--therapeutic use<br/>Prostaglandins--therapeutic use<br/>Remission Induction<br/>Topotecan--administration & dosage<br/>Transplantation Conditioning<br/>Transplantation, Homologous<br/>Vidarabine--analogs & derivatives<br/>Whole-Body Irradiation